Edwards Lifesciences Corp Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: November 4, 2026 results vs estimates
Edwards Lifesciences Corp Forecast
Edwards Lifesciences Corp short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 22.4% a year, a typical one-standard-deviation range is 91.46–97.42 over a week, 88.34–100.54 over a month and 73.29–115.59 over a year. (Signals as of 1 Nov 2026.)
Edwards Lifesciences Corp Price Chart
Edwards Lifesciences Corp Factors
YoY +46.5%
YoY −3.6%
YoY +2.8%
YoY +61.5%
YoY −4.5%
YoY +7.9%
YoY −31.8%
YoY +9.4%
YoY +25.4%
YoY +86.9%
YoY +14.8%
YoY +17.5%
YoY −5.4%
YoY +16.7%
YoY +4.7%
Edwards Lifesciences Corp fundamentals: income statement, balance sheet & cash flow
Edwards Lifesciences Corp reported revenue of $6.07bn and net income of $1.07bn in FY2025, the year ended 31 December 2025 — revenue up 11.5% and net income down 74.3% on the prior year. Free cash flow was $1.34bn. These figures are as reported in the filings, not restated: 27 fiscal years and 108 quarters of history, back to December 1999. 173 FINRA short-interest settlements are published alongside them, back to June 2019.
| USD millions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 6,067.6 | 5,439.5 | 6,004.8 | 5,382.4 | 5,232.5 |
| Cost of revenue | 1,326.9 | 1,117.5 | 1,379.8 | 1,167.2 | 1,225.9 |
| Gross profit | 4,740.7 | 4,322.0 | 4,625.0 | 4,215.2 | 4,006.6 |
| Research & development | 1,079.2 | 1,053.0 | 1,071.8 | 945.2 | 903.1 |
| Selling, general & admin. | — | — | — | 1,566.5 | 1,494.0 |
| Operating income | 1,636.2 | 1,378.7 | 1,534.1 | 1,702.4 | 1,610.4 |
| EBITDA | 1,429.5 | 1,723.1 | 1,534.1 | 1,933.2 | 1,861.6 |
| Interest expense | 20.4 | 19.8 | 17.6 | 26.2 | 24.8 |
| Pre-tax income | 1,272.9 | 1,548.1 | 1,598.1 | 1,767.4 | 1,702.0 |
| Income tax | 216.9 | 152.1 | 198.7 | 245.5 | 198.9 |
| Net income | 1,073.5 | 4,174.6 | 1,402.4 | 1,521.9 | 1,503.1 |
Download Edwards Lifesciences Corp fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.EW.NYSE&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on Edwards Lifesciences Corp
Explore MacroFinance macro & markets research and analysis.
Edwards Lifesciences Corp Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Edwards Lifesciences Corp; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow Edwards Lifesciences Corp’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Edwards Lifesciences Corp (United States)
Edwards Lifesciences Corp is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on East West Banking Corp
Frequently asked questions
What is Edwards Lifesciences Corp?
What is the latest Edwards Lifesciences Corp price?
Is Edwards Lifesciences Corp in an uptrend?
How volatile is Edwards Lifesciences Corp?
What factors affect Edwards Lifesciences Corp?
Which trading strategies trade Edwards Lifesciences Corp?
How are Edwards Lifesciences Corp returns analysed?
Where can I download free Edwards Lifesciences Corp historical data?
Free Edwards Lifesciences Corp historical data (last 10 years)
Browse or instantly download the last 10 years of Edwards Lifesciences Corp daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.EW.NYSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 101.85 |
| 2026-11-19 | 103.88 |
| 2026-11-18 | 105.23 |
| 2026-11-17 | 105.43 |
| 2026-11-16 | 107.11 |
| 2026-11-13 | 107.15 |
| 2026-11-12 | 105.8 |
| 2026-11-11 | 105.81 |
| 2026-11-10 | 104.01 |
| 2026-11-09 | 104.71 |
About this stock
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.